Clint Sever - Nov 22, 2022 Form 4 Insider Report for Cue Health Inc. (HLTH)

Role
Chief Product Officer
Signature
/s/ Erica Palsis, Attorney-in-Fact for Clint Sever
Stock symbol
HLTH
Transactions as of
Nov 22, 2022
Transactions value $
-$134,005
Form type
4
Date filed
11/25/2022, 05:07 PM
Previous filing
Nov 10, 2022
Next filing
Dec 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLTH Common Stock Options Exercise $3.82K +19.1K +0.48% $0.20 3.97M Nov 22, 2022 Direct F1
transaction HLTH Common Stock Sale -$48.9K -19.1K -0.48% $2.56* 3.95M Nov 22, 2022 Direct F1, F2
transaction HLTH Common Stock Options Exercise $3.82K +19.1K +0.48% $0.20 3.97M Nov 23, 2022 Direct F1
transaction HLTH Common Stock Sale -$49.2K -19.1K -0.48% $2.58* 3.95M Nov 23, 2022 Direct F1, F3
transaction HLTH Common Stock Options Exercise $3.82K +19.1K +0.48% $0.20 3.97M Nov 25, 2022 Direct F1
transaction HLTH Common Stock Sale -$47.3K -19.1K -0.48% $2.48* 3.95M Nov 25, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -19.1K -11.93% $0.00 141K Nov 22, 2022 Common Stock 19.1K $0.20 Direct F1, F5
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -19.1K -13.54% $0.00 122K Nov 23, 2022 Common Stock 19.1K $0.20 Direct F1, F5
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -19.1K -15.66% $0.00 103K Nov 25, 2022 Common Stock 19.1K $0.20 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.49 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.63, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.53, inclusive.
F5 Shares subject to the option are fully vested and immediately exercisable.